Ðǿմ«Ã½

    Advertisement

    We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

    In the last 8 hours
    News-Medical.Net02:39
    Yesterday
    LabOnline20:35 7-May-26
    ecancer10:12 7-May-26
    Business Wire (Press Release)09:09 7-May-26
    In the last 7 days
    News-Medical.Net21:36 6-May-26
    Nature.com11:27 6-May-26
    Nature.com11:27 6-May-26
    Nature.com11:03 6-May-26
    Nature.com11:03 6-May-26
    Newswise (Press Release)11:02 6-May-26
    Simply Wall St06:07 6-May-26
    Labiotech05:23 6-May-26
    News-Medical.Net22:33 5-May-26
    Barchart14:10 5-May-26
    Penn State News11:43 5-May-26
    Rare Disease Advisor11:07 5-May-26
    Pharmaceutical Technology10:57 5-May-26
    Zacks09:27 5-May-26
    Scientific American07:55 5-May-26
    Business Wire (Press Release)07:01 5-May-26
    Zacks20:33 4-May-26
    Drug Discovery & Development17:31 4-May-26
    Rare Disease Advisor15:04 4-May-26
    Rare Disease Advisor14:44 4-May-26
    Rare Disease Advisor12:22 4-May-26
    UQ News10:19 4-May-26
    Gulf News19:19 3-May-26
    Vox07:54 2-May-26
    The Scientist00:10 2-May-26
    PR Newswire (Press Release)16:02 1-May-26
    American College of Cardiology08:03 1-May-26
    In the last month
    News-Medical.Net14:46 30-Apr-26
    Newswise (Press Release)11:59 30-Apr-26
    Reason11:43 30-Apr-26
    PR Newswire (Press Release)08:31 30-Apr-26
    Business Wire (Press Release)08:08 30-Apr-26
    Business Wire (Press Release)07:05 30-Apr-26
    Reason06:17 30-Apr-26
    University of Bonn06:14 30-Apr-26
    The Motley Fool05:20 30-Apr-26
    Labiotech04:03 30-Apr-26
    The Motley Fool11:31 29-Apr-26
    Nature.com11:22 29-Apr-26
    Nature.com11:06 29-Apr-26
    Nature.com11:06 29-Apr-26
    The Cardiology Advisor09:38 29-Apr-26
    Business Wire (Press Release)08:01 29-Apr-26
    Business Wire (Press Release)07:03 29-Apr-26
    Pharmaceutical Technology07:02 29-Apr-26
    South Wales Argus00:12 29-Apr-26
    Simply Wall St22:00 28-Apr-26
    Nature.com21:30 28-Apr-26
    Hoodline19:45 28-Apr-26
    Zacks19:02 28-Apr-26
    Scrip Pharma Intelligence17:08 28-Apr-26
    Benzinga15:08 28-Apr-26
    Zacks14:07 28-Apr-26
    JD Supra14:04 28-Apr-26
    pharmaphorum08:36 28-Apr-26
    Business Wire (Press Release)07:02 28-Apr-26
    IFLScience06:33 28-Apr-26
    Farming UK04:27 28-Apr-26
    Nature.com03:03 28-Apr-26
    RTT News21:15 27-Apr-26
    Bloomberg Law17:12 27-Apr-26
    Barchart14:49 27-Apr-26
    Investing.com UK13:03 27-Apr-26
    Clinical Trials Arena12:14 27-Apr-26
    BioPharma Dive10:17 27-Apr-26
    JD Supra10:07 27-Apr-26
    pharmaphorum09:41 27-Apr-26
    STAT09:29 27-Apr-26
    Zacks09:10 27-Apr-26
    STAT07:05 27-Apr-26
    News-Medical.Net13:10 26-Apr-26
    Nature.com09:02 25-Apr-26
    RTT News07:08 25-Apr-26
    NOEMA13:04 24-Apr-26
    ZME Science10:01 24-Apr-26
    Simply Wall St10:01 24-Apr-26
    view more headlines
    8 May 02:39

    About our CRISPR/Gene Editing news

    Latest news on CRISPR/Gene Editing, covering breakthroughs, applications, ethics, regulations, and implications for health, agriculture, and biotechnology. Stay informed on this revolutionary technology.

    CRISPR/Cas9, the groundbreaking gene-editing tool, has revolutionised the field of genetics and biotechnology since its discovery in 2012. Developed by scientists Jennifer Doudna and Emmanuelle Charpentier, who were awarded the Nobel Prize in Chemistry in 2020, CRISPR allows for precise, efficient, and cost-effective editing of DNA sequences in living organisms.

    The potential applications of CRISPR are vast, spanning healthcare, agriculture, and beyond. In medicine, CRISPR holds promise for treating genetic disorders, developing novel therapies for diseases like cancer and HIV, and even potentially enhancing human traits. Recent breakthroughs include the first clinical trials of CRISPR-based treatments for sickle cell anemia and beta-thalassemia, as well as advancements in using CRISPR to target antibiotic-resistant bacteria.

    In agriculture, CRISPR is being explored to develop more resilient, nutritious, and sustainable crops, as well as to create disease-resistant livestock. Companies like Corteva Agriscience and Calyxt are at the forefront of these efforts. However, the use of CRISPR in agriculture has also sparked debates about GMO regulations, labelling, and public acceptance.

    Despite its immense potential, CRISPR also raises significant ethical and societal concerns. The prospect of human germline editing, which could alter the genetic makeup of future generations, has been particularly controversial. In 2018, Chinese scientist He Jiankui claimed to have created the world's first gene-edited babies, sparking global outcry and calls for stricter oversight. Organizations like the World Health Organization and the National Academies of Sciences have issued guidelines and recommendations for the responsible development and governance of gene editing.

    Stay up-to-date on the latest CRISPR/Gene Editing news with our dedicated feed, covering everything from cutting-edge research and clinical trials to policy developments and societal debates, as this transformative technology continues to shape our future.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.